AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
DiaMedica Therapeutics Inc. Common Stock
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SQ3K65
8.72▲ 0.09 (1.04%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
8.63
Day's Range
8.29 – 8.79
52-Week Range
5.25 – 10.42
Volume
110.0K
Avg Volume
220.9K
Share Statistics
Shares Outstanding
Employees
35
Exchange
XNAS
Listed
2007-11-29
Share count as of August 3, 2026

DiaMedica Therapeutics Inc. Common Stock (DMAC) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about DiaMedica Therapeutics Inc. Common Stock (DMAC)
What is DiaMedica Therapeutics Inc. Common Stock's Market Cap?
DiaMedica Therapeutics Inc. Common Stock's Market Cap is $470.2M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Enterprise Value?
DiaMedica Therapeutics Inc. Common Stock's Enterprise Value is $426.7M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's EV / EBITDA?
DiaMedica Therapeutics Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Net Income (TTM)?
DiaMedica Therapeutics Inc. Common Stock's Net Income (TTM) is -$37.5M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's EBITDA?
DiaMedica Therapeutics Inc. Common Stock's EBITDA is -$39.2M, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Diluted EPS (TTM)?
DiaMedica Therapeutics Inc. Common Stock's Diluted EPS (TTM) is -0.70, based on as-reported figures from SEC (XBRL) filings.
What is DiaMedica Therapeutics Inc. Common Stock's Net Debt?
DiaMedica Therapeutics Inc. Common Stock's Net Debt is -$43.5M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · DMACAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Research and development
General and administrative
Operating loss
Other income, net
Loss before income tax expense
Income tax expense
Net loss
Basic and diluted net loss per share (in dollars per share)